Search - tctmd.com

Displaying 341 - 360 of 462

Sort: Relevancy | Date

Presentation TCT 2013

Cases III and IV: Left Main and Bifurcation Lesions

Presenter: Bon-Kwon Koo

October 31, 2013

News Industry News

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

October 31, 2013

Presentation TCT 2013

NORDIC-BALTIC BIFURCATION IV: A Prospective, Randomized Trial of a Two-Stent Strategy vs. a Provisional Stent Strategy in True Coronary Bifurcation Lesions

Presenter: Indulis Kumsars

October 30, 2013

Presentation TCT 2013

TRYTON: A Prospective, Randomized Trial of a Dedicated Side Branch Stent vs. a Provisional Stent Strategy in True Coronary Bifurcation Lesions

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

IVUS in Non-Left Main Bifurcation Lesions

Presenter: Jasvindar Singh

October 30, 2013

Presentation TCT 2013

FFR in Non-Left Main Bifurcation Lesions

Presenter: Bon-Kwon Koo

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Industry News

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

October 30, 2013

News Industry News

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

October 30, 2013

News Industry News

New Study Compares Provisional and Two-Stent Strategies for Coronary Bifurcation Lesions

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

Presentation TCT 2013

To cover or not to cover deep femoral arteries in stenting for bifurcation lesions of superficial femoral artery

Presenter: Sung-Jin Hong

October 29, 2013

Presentation TCT 2013

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

Presenter: Toru Naganuma

October 29, 2013

Presentation TCT 2013

TCT-26. Randomized Comparison Of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation In Patients With Coronary Bifurcation Lesions Treated With Main Vess...

Presenter: Niels Holm

October 29, 2013

Presentation TCT 2013

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

Presenter: Christoph Naber

October 29, 2013

Presentation TCT 2013

Meta-analysis of Long Term Outcomes of Intravascular Ultrasound versus Angiographic-Guided Percutaneous Coronary Intervention of Bifurcation Lesions

Presenter: VG Patel

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

Presentation TCT 2013

Treatment of Coronary Bifurcation Lesions with a Self-Expanding DES: 6-Month Results from the OPEN II Trial

Presenter: Christoph Naber

October 28, 2013

Presentation TCT 2013

Are There Meaningful Clinical Differences between Different DES in Left Main Bifurcation and Non-bifurcation Lesions? The ISAR Left Main Trials and Other Data

Presenter: Adnan Kastrati

October 28, 2013

Presentation TCT 2013

Drug-coated Balloons for Bifurcation Lesions: Rationale, Practice, and Evidence

Presenter: Kenneth Chin

October 28, 2013

Advertisement

Cases III and IV: Left Main and Bifurcation Lesions

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

NORDIC-BALTIC BIFURCATION IV: A Prospective, Randomized Trial of a Two-Stent Strategy vs. a Provisional Stent Strategy in True Coronary Bifurcation Lesions

TRYTON: A Prospective, Randomized Trial of a Dedicated Side Branch Stent vs. a Provisional Stent Strategy in True Coronary Bifurcation Lesions

IVUS in Non-Left Main Bifurcation Lesions

FFR in Non-Left Main Bifurcation Lesions

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

New Study Compares Provisional and Two-Stent Strategies for Coronary Bifurcation Lesions

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

To cover or not to cover deep femoral arteries in stenting for bifurcation lesions of superficial femoral artery

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

TCT-26. Randomized Comparison Of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation In Patients With Coronary Bifurcation Lesions Treated With Main Vess...

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

Meta-analysis of Long Term Outcomes of Intravascular Ultrasound versus Angiographic-Guided Percutaneous Coronary Intervention of Bifurcation Lesions

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

Treatment of Coronary Bifurcation Lesions with a Self-Expanding DES: 6-Month Results from the OPEN II Trial

Are There Meaningful Clinical Differences between Different DES in Left Main Bifurcation and Non-bifurcation Lesions? The ISAR Left Main Trials and Other Data

Drug-coated Balloons for Bifurcation Lesions: Rationale, Practice, and Evidence

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content